Houston Methodist · Mar 2025
Describes Houston Methodist’s leading role in the SAVE Fistulas randomized controlled trial and notes the trial is evaluating VenoStent’s SelfWrap bioabsorbable wrap for CKD patients needing AV fistulas.
Company research
Public company, workplace, funding, and market signals
Overview
VenoStent is a Houston-based, clinical-stage therapeutic medical device company developing SelfWrap, a bioabsorbable perivascular wrap used during arteriovenous fistula creation to improve maturation and patency for dialysis access.
Primary product
SelfWrap bioabsorbable perivascular wrap
Founded
2017
Headquarters
Houston, Texas, United States
Team size
11-50
Work style
Onsite
Industry
Medical Device
Sub-industry
Vascular surgery / tissue engineering
Offices
Houston, Texas, United States
Open Positions
0 jobs at VenoStent
No open positions
Check back later for new openings